PRXV - ETF AI Analysis
Top Page
Praxis Impact Large Cap Value ETF (PRXV)
Rating:72Outperform
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and over the past few months, showing solid recent momentum.
Leading Blue-Chip Holdings
Top positions in well-known companies like Micron, JPMorgan Chase, Johnson & Johnson, and other large, established firms have generally contributed positively to returns.
Broad Sector Diversification
Holdings spread across financials, health care, technology, industrials, consumer sectors, and more help reduce the impact if any one industry weakens.
Negative Factors
High U.S. Concentration
With almost all assets invested in U.S. companies, the fund offers little geographic diversification and is heavily tied to the U.S. economy.
Moderate Expense Ratio
The fund’s expense ratio is not especially low, which means fees may eat into returns more than with some cheaper index ETFs.
Sector Tilts Toward Financials and Health Care
A relatively large allocation to financial and health care stocks means the fund could be more sensitive if those sectors face pressure.
PRXV vs. SPDR S&P 500 ETF (SPY)
AUM89.83M
RegionNorth America
Expense Ratio0.36%
Beta0.54
IssuerPraxis
Inception DateApr 07, 2025
Dividend Yield1.55%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume9,938
30 Day Avg. Volume11,826
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
41.59Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering270
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PRXV Summary
Praxis Impact Large Cap Value ETF (PRXV) is a U.S. stock fund that focuses on large, established companies that appear undervalued and also meet environmental, social, and governance (ESG) standards. It does not track a set index, but instead selects stocks across many sectors like financials, health care, and technology. Well-known holdings include JPMorgan Chase and Johnson & Johnson. Someone might invest in PRXV to seek long-term growth while aligning their money with their values and gaining diversification across many industries. A key risk is that its stock prices can rise and fall with the overall market and with value-style companies in particular.
How much will it cost me?The Praxis Impact Large Cap Value ETF (PRXV) has an expense ratio of 0.36%, which means you’ll pay $3.60 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed and focuses on socially responsible investing, which requires more research and oversight. It’s a good option if you value ethical considerations alongside financial returns.
What would affect this ETF?The PRXV ETF, with its focus on large-cap value stocks and ESG criteria, could benefit from increased investor interest in socially responsible investing and strong performance in sectors like financials and healthcare. However, it may face challenges if economic conditions weaken, particularly in North America, or if regulatory changes impact ESG-focused investments. Sector-specific risks, such as volatility in energy or technology, could also influence its future performance.
PRXV Top 10 Holdings
PRXV leans into U.S. large-cap value with a clear tilt toward big banks and steady blue chips. JPMorgan and Bank of America are key financial anchors, though both have been lagging lately and can act like a brake on returns. On the brighter side, Micron and Cisco are rising tech names tied to AI demand, giving the fund some growth spark. Defensive staples like Johnson & Johnson, AbbVie, Coca-Cola, and Procter & Gamble provide a steady, dividend-rich backbone, helping smooth out the bumps from more volatile sectors.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Micron | 4.47% | $4.01M | $1.22T | 543.06% | 79 Outperform | |
| JPMorgan Chase | 3.53% | $3.17M | $911.92B | 6.62% | 72 Outperform | |
| Johnson & Johnson | 2.85% | $2.56M | $653.61B | 49.74% | 78 Outperform | |
| AbbVie | 2.03% | $1.82M | $467.12B | 19.32% | 66 Neutral | |
| Walmart | 1.84% | $1.65M | $856.69B | 5.48% | 78 Outperform | |
| Conocophillips | 1.83% | $1.64M | $152.93B | 31.50% | 78 Outperform | |
| Coca-Cola | 1.74% | $1.56M | $377.81B | 32.01% | 75 Outperform | |
| Procter & Gamble | 1.61% | $1.45M | $339.64B | -2.93% | 69 Neutral | |
| Cisco Systems | 1.59% | $1.43M | $420.67B | 57.62% | 77 Outperform | |
| Bank of America | 1.50% | $1.35M | $396.49B | 5.82% | 72 Outperform |
PRXV Technical Analysis
Negative
―
Price Trends
35.71
Negative
34.87
Negative
33.09
Positive
Market Momentum
-0.25
Positive
31.84
Neutral
-1.90
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PRXV, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 35.48, equal to the 50-day MA of 35.71, and equal to the 200-day MA of 33.09, indicating a neutral trend. The MACD of -0.25 indicates Positive momentum. The RSI at 31.84 is Neutral, neither overbought nor oversold. The STOCH value of -1.90 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PRXV.
PRXV Peer Comparison
Comparison Results
Performance Comparison
PRXV
Praxis Impact Large Cap Value ETF
34.63
5.46
18.72%
MAVF
Matrix Advisors Value ETF
―
―
―
NSIV
North Square Disciplined Value ETF
―
―
―
DHLX
Diamond Hill Large Cap Concentrated ETF
―
―
―
PZLV
Pzena U.S. Large Cap Value ETF
―
―
―
DVAL
BrandywineGLOBAL - Dynamic US Large Cap Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents